WebIn terms of dividends, Ionis Pharmaceuticals Inc has a dividend per share of 0 and a dividend yield of 0. The company's most recent dividend date was None, and the ex-dividend date was None. IONS's financials reveal a book value of 4.033 and earnings per share (EPS) of -1.88, with a diluted EPS (TTM) of -1.88. WebWith RNA as the basis of our discovery platform, we are able to bring therapeutic options to patients who otherwise would have none. Our antisense therapies are designed to interact precisely with RNA, allowing us to create treatments that disrupt the disease process and change its course. With three approved best- and first-in-class medicines ...
Ionis Pharmaceuticals - Stock Price History IONS MacroTrends
Web14 aug. 2024 · News Ionis Pharmaceuticals Inc. Significant News Only No significant news for IONS in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-1.90 … Web29 mrt. 2024 · Get Ionis Pharmaceuticals Inc historical price data for IONS stock. Investing.com has all the historical stock data including the closing price, open, high, low, change and % change. titleist bottle
Ionis Pharmaceuticals (NASDAQ:IONS) Price Target Raised to $42.00
Web31 mrt. 2024 · Alkermes currently has a consensus price target of $30.75, indicating a potential upside of 2.91%. Ionis Pharmaceuticals has a consensus price target of $45.33, indicating a potential upside of 20.70%. Given Ionis Pharmaceuticals' higher probable upside, analysts clearly believe Ionis Pharmaceuticals is more favorable than Alkermes. Web7 apr. 2024 · See the latest Ionis Pharmaceuticals Inc stock price (XDUS:ISI), related news, valuation, dividends and more to help you make your investing decisions. Web9 apr. 2024 · Xponance Inc. boosted its position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) ... The stock was sold at an average price of $39.49, for a total value of $989,856.34. titleist bounce chart